Zai Lab (shanghai) Co., Ltd.

This study tests a new drug called ZL-1310, given alone or with other medicines, for people with small cell lung cancer. The goal is to see if it is safe and helps control the cancer. About 339 adults with advanced or spreading small cell lung cancer will take part. The study is …

This study tests a new drug, ZL-1310, designed to target and kill cancer cells in people with small cell lung cancer that has returned after initial treatment. About 480 adults will receive either ZL-1310 or a standard treatment chosen by their doctor. The goal is to see if ZL-13…

This phase 3 trial tests whether ZL-1109 can reduce eye bulging and other symptoms in 99 Chinese adults with moderate to severe thyroid eye disease. Participants receive either the drug or a placebo, and doctors measure changes in eye position over time. The study is currently re…

This early-stage study tests a new drug called ZL-6201 in adults with sarcoma or certain solid tumors that have spread or cannot be removed by surgery. The main goals are to check the drug's safety and find the right dose. About 180 participants will take part to see if the drug …

This study tests an experimental drug called ZL-1310 in about 112 adults with advanced neuroendocrine carcinomas that have worsened after standard chemotherapy. The goal is to see if the drug can shrink tumors and to check for side effects. Participants will receive the drug and …

This early-stage study tests whether a new drug called ZL-1503 is safe for people with moderate to severe atopic dermatitis (eczema). It involves 84 participants, including healthy volunteers and those with eczema, who receive either the drug or a placebo. The main goal is to che…